COOLOGICS Launches Multi-Center Trials for Novel Cooling Device to Treat Vaginal Yeast Infections

grdirks
Apr 10, 2025
1 min read

Updated: Feb 10

COOLOGICSSearch company, a Cleveland-based clinical-stage medical device company, announced this month the initiation of multi-center, open-label clinical trials for VlisseSearch drug, its innovative intravaginal cooling device designed to treat vulvovaginal candidiasis (VVC)Search disease, commonly known as yeast infectionsSearch disease.

Recent Posts

See All

Florida Angels Join $4.7M Hyperspectral Imaging Round, AI Writes up to One-Third of Microsoft's Code, and Why Clarity is Kindness

Coologics | Drug-free vaginal infection treatment Participating Groups: Ohio State Early Investor Network , Illini Angels Coologics is developing a drug-free intravaginal cooling device called Vlisse

Coologics Secures $3M for Drug-Free Vaginal Infection Treatment Device

Coologics , a US-based clinical-stage medical device company, has successfully closed an oversubscribed seed funding round, raising over $3 million for its innovative vaginal infection treatment devic

Cleveland women's healthtech startup secures $3M, doubling initial target

A Cleveland-based clinical-stage medical device company announced it has closed an oversubscribed $3 million seed funding round, doubling the initial $1.5 million target. Read more.

Comments

Vlisse™ is a Class I Device in the European Union CE Mark Pending and a FDA Class II device pending FDA clearance.